These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35077577)

  • 1. Detection of revertant mosaicism in epidermolysis bullosa through Cas9-targeted long-read sequencing.
    Natsuga K; Furuta Y; Takashima S; Nohara T; Kosumi H; Mai Y; Higashi H; Ujiie H
    Hum Mutat; 2022 Apr; 43(4):529-536. PubMed ID: 35077577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revertant mosaicism due to a second-site mutation in COL7A1 in a patient with recessive dystrophic epidermolysis bullosa.
    Pasmooij AM; Garcia M; Escamez MJ; Nijenhuis AM; Azon A; Cuadrado-Corrales N; Jonkman MF; Del Rio M
    J Invest Dermatol; 2010 Oct; 130(10):2407-11. PubMed ID: 20574443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural gene therapy in dystrophic epidermolysis bullosa.
    van den Akker PC; Nijenhuis M; Meijer G; Hofstra RM; Jonkman MF; Pasmooij AM
    Arch Dermatol; 2012 Feb; 148(2):213-6. PubMed ID: 22004882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revertant mosaic fibroblasts in recessive dystrophic epidermolysis bullosa.
    Twaroski K; Eide C; Riddle MJ; Xia L; Lees CJ; Chen W; Mathews W; Keene DR; McGrath JA; Tolar J
    Br J Dermatol; 2019 Dec; 181(6):1247-1253. PubMed ID: 30924923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cas9-guided haplotyping of three truncation variants in autosomal recessive disease.
    Natsuga K; Furuta Y; Takashima S; Nohara T; Huang HY; Shinkuma S; Nakamura H; Katsuda Y; Higashi H; Hsu CK; Fukushima S; Ujiie H
    Hum Mutat; 2022 Jul; 43(7):877-881. PubMed ID: 35446444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of natural gene therapy in dystrophic epidermolysis bullosa.
    Kiritsi D; Garcia M; Brander R; Has C; Meijer R; Jose Escámez M; Kohlhase J; van den Akker PC; Scheffer H; Jonkman MF; Del Rio M; Bruckner-Tuderman L; Pasmooij AMG
    J Invest Dermatol; 2014 Aug; 134(8):2097-2104. PubMed ID: 24577406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa.
    Hainzl S; Peking P; Kocher T; Murauer EM; Larcher F; Del Rio M; Duarte B; Steiner M; Klausegger A; Bauer JW; Reichelt J; Koller U
    Mol Ther; 2017 Nov; 25(11):2573-2584. PubMed ID: 28800953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revertant mosaicism in recessive dystrophic epidermolysis bullosa.
    Almaani N; Nagy N; Liu L; Dopping-Hepenstal PJ; Lai-Cheong JE; Clements SE; Techanukul T; Tanaka A; Mellerio JE; McGrath JA
    J Invest Dermatol; 2010 Jul; 130(7):1937-40. PubMed ID: 20357813
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinically Relevant Correction of Recessive Dystrophic Epidermolysis Bullosa by Dual sgRNA CRISPR/Cas9-Mediated Gene Editing.
    Bonafont J; Mencía Á; García M; Torres R; Rodríguez S; Carretero M; Chacón-Solano E; Modamio-Høybjør S; Marinas L; León C; Escamez MJ; Hausser I; Del Río M; Murillas R; Larcher F
    Mol Ther; 2019 May; 27(5):986-998. PubMed ID: 30930113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Case Report of an Infant with Autosomal Recessive Dystrophic Epidermolysis Bullosa: COL7A1 Gene Mutations at C2005T and G7922A.
    Liu J; Wang L
    Acta Dermatovenerol Croat; 2021 Dec; 29(3):164-166. PubMed ID: 34990346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic mosaicism for the COL7A1 mutation p.Gly2034Arg in the unaffected mother of a patient with dystrophic epidermolysis bullosa pruriginosa.
    van den Akker PC; Pasmooij AM; Meijer R; Scheffer H; Jonkman MF
    Br J Dermatol; 2015 Mar; 172(3):778-81. PubMed ID: 25113066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild recessive dystrophic epidermolysis bullosa associated with two compound heterozygous COL7A1 mutations.
    von Bartenwerffer W; Has C; Arin MJ; Tantcheva-Poór I; Kreuter A; Kremer K; Arshah T; Hoffmann M; Eming SA; Kohlhase J; Krieg T; Bruckner-Tuderman L; Hartmann K
    Eur J Dermatol; 2011; 21(2):170-2. PubMed ID: 21382783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel COL7A1 gene mutation in an Iranian individual suffering dystrophic epidermolysis bullosa.
    Galehdari H; Mohammadian G; Azmoon S; Salehi B; Pedram M
    J Mol Diagn; 2010 May; 12(3):377-9. PubMed ID: 20190017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system.
    Itoh M; Kawagoe S; Tamai K; Nakagawa H; Asahina A; Okano HJ
    J Dermatol Sci; 2020 Jun; 98(3):163-172. PubMed ID: 32376152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient Gene Reframing Therapy for Recessive Dystrophic Epidermolysis Bullosa with CRISPR/Cas9.
    Takashima S; Shinkuma S; Fujita Y; Nomura T; Ujiie H; Natsuga K; Iwata H; Nakamura H; Vorobyev A; Abe R; Shimizu H
    J Invest Dermatol; 2019 Aug; 139(8):1711-1721.e4. PubMed ID: 30831133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermolysis Bullosa (EB) Acquisita in an Adult Patient with Previously Unrecognized Mild Dystrophic EB and Biallelic COL7A1 Mutations.
    Guerra L; Condorelli AG; Fortugno P; Calabresi V; Pedicelli C; Di Zenzo G; Castiglia D
    Acta Derm Venereol; 2018 Apr; 98(4):411-415. PubMed ID: 29182795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cultured Epidermal Autografts from Clinically Revertant Skin as a Potential Wound Treatment for Recessive Dystrophic Epidermolysis Bullosa.
    Matsumura W; Fujita Y; Shinkuma S; Suzuki S; Yokoshiki S; Goto H; Hayashi H; Ono K; Inoie M; Takashima S; Nakayama C; Nomura T; Nakamura H; Abe R; Sato N; Shimizu H
    J Invest Dermatol; 2019 Oct; 139(10):2115-2124.e11. PubMed ID: 31054844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dystrophic epidermolysis bullosa with one dominant and one recessive mutation of the COL7A1 gene in a child with deafness.
    Weinel S; Lucky AW; Uitto J; Pfendner EG; Choo D
    Pediatr Dermatol; 2008; 25(2):210-4. PubMed ID: 18429782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene diagnosis and prenatal genetic diagnosis of a case of dystrophic epidermolysis bullosa family caused by gonadosomatic mosaicism for the COL7A1 mutation p.Gly2043Arg in the pregnant mother.
    Shen J; Zhang J; Wang Z; Ni C; Li H; Cheng R; Liang J; Li M; Yao Z
    J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1627-9. PubMed ID: 26289024
    [No Abstract]   [Full Text] [Related]  

  • 20. [Recessive epidermolysis bullosa due to composite heterozygote mutations in the COL7A1 gene].
    Abdou A; Daoui L; Charlesworth A; Chiaverini C; Algros MP; Puzenat E; Chantegret C; Vabres P; Lacour JP; Aubin F
    Ann Dermatol Venereol; 2015 May; 142(5):346-9. PubMed ID: 25683012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.